DTU Logo
About the DTU | News | Staff | Alumni | Contact/Find us

News


Search news :

ISAT Trial results published

26-Oct-2002
News Image The results of the ISAT trial have been published in The Lancet

[Link]

EuroDREAM project office

17-Sep-2002
News Image The Diabetes Trials Unit has set up a EuroDREAM project office to help manage those european clinical centres that are participating in the DREAM study.

[Link]

UKPDS paper 60 published in Stroke

09-Jul-2002
News Image UKPDS 60 Risk of stroke in type 2 diabetes estimated by the UKPDS risk engine
Kothari V, Stevens RJ, Adler AI, Stratton IM, Manley SE, Neil HAW, Holman RR
Stroke (2002); 33: 1776-1781

[Link]

DTU abstracts at ADA 2002

07-Jun-2002
News Image Retinopathy in Type 2 Diabetes - When Does the Clock Start Ticking? Rury R Holman, Susan E Manley, Andrew E Neil, David R Matthews and Irene M Stratton. Diabetes 2002; 51: Supplement (2) A64

Changing Aspirin Use in the UK Patients with Type 2 Diabetes....

[Read more...]

Appointment of the first Robert Turner Professor of Diabetes

24-May-2002
News Image Professor Mark McCarthy, currently Professor of Genomic Medicine at Imperial College, London and Honorary Consultant Physician at St Mary's Hospital, has been elected to the newly created Robert Turner Professorship of Diabetic Medicine.
The Chair, which has been endowed by Servier Laboratories, will be attached to the Oxford Centre for Diabetes, Endocrinology and Metabolism(OCDEM)....

[Read more...]

UKPDS Risk Engine FAQ available

23-May-2002
News Image A list of frequently asked questions (FAQ) and answers is now available.

[Link]

Homocysteine as a risk factor for cardiovascular disease publication

08-May-2002
News Image Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
Clarke R, Lewington S, Donald A, Johnston C, Refsum H, Stratton I, Jacques P, Breteler MM, Holman R
Journal of Cardiovascular Risk 2001; 8(6): 363-9

[Link]

LDS Close out

26-Mar-2002
News Image Following the withdrawal of cerivastatin by Bayer in August 2001, the Lipids in Diabetes Study (LDS) was put on hold and the 4191 randomised subjects asked to stop all study medication temporarily. In light of this, and the release of the Heart Protection Study (HPS) results, major efforts were made to restart the LDS using a modified design....

[Read more...]

UKPDS Risk Engine v1.0 released

26-Mar-2002
News Image Version 1.0 of the UKPDS Risk Engine provides risk estimates and 95% confidence intervals for both coronary heart disease and stroke in individuals with type 2 diabetes not known to have heart disease. These can be calculated for any given duration of type 2 diabetes based on current age, sex, ethnicity, smoking status, presence or absence of atrial fibrillation and levels of HbA1c, systolic blood pressure, total cholesterol and HDL cholesterol.

[Link]